Nanoparticles in Biotechnology, Drug Development, and Drug Delivery

September 27, 2012

Wellesley, Mass. – According to a new technical market research report, NANOPARTICLES IN BIOTECHNOLOGY, DRUG DEVELOPMENT AND DRUG DELIVERY (BIO113A) from BCC Research (www.bccresearch.com), the global market for nanoparticles in biotechnology, drug development and drug delivery was valued at $17.5 billion in 2011 and should reach nearly $21.6 billion in 2012. Total market value is expected to reach $53.5 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 19.9%.

The market for nanoparticles in biotechnology and pharmaceuticals can be broken down into four segments: biotechnology applications, drug development and formulation, drug delivery systems, and diagnostic imaging and testing.

Biotechnology applications are expected to increase from $388 million in 2012 to more than $1 billion in 2017, a CAGR of 21%.

Drug development and formulation should total nearly $9.4 billion in 2012 and nearly $20.5 billion in 2017, a CAGR of 16.9%.

Drug delivery systems are expected to increase from $11.3 billion in 2012 to $30.9 billion in 2017, a CAGR of 22.2%.

Diagnostic imaging and testing should increase from $466 million in 2012 to $1.1 billion in 2017, a CAGR of 19.6%.

In the last decade, the science of nanoparticles has made major advances in particle type production and in nanoparticle application in all areas of the life sciences.  The most rapid advances have been made in the application of nanoparticles in drug research and development, drug product formulation, and development of novel drug delivery systems using nanoparticle carriers. The development of nanoparticles and their rapid incorporation into the research and development, formulation, and production of drug products has given rise to the need for rapid and accurate analytical instrumentation that is necessary for determining the size and characteristics of particle materials in the nanometer size range. 

This report will help its readers:

• Gain a comprehensive analysis of the market for nanoparticles in the life sciences on a global basis
• Analyze current and projected product forecasts during the forecast period of 2012 through 2017
• Analyze leading and emerging drug products for each nanoparticle type
• View profiles of manufacturers of leading products and their specific products as well as assess companies poised to introduce products during the forecast period
• Review relevant patent and clinical trial information. 

This report is an invaluable tool for business planners, acquisitions specialists, licensing strategists, product managers, market research analysts, investors, investor consultants, and anyone interested in the nanoparticle drug market, its products, its industry participants, and its future.

To Contact us, click here  

Nanoparticles in Biotechnology, Drug Development and Drug Delivery( BIO113A )
Publish Date: Sep 2012    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.